Trial Profile
An Open-Label Study of the Tolerability and Flexibility of Multi-Dose NeoRecormon Administered by Reco-Pen in Pre-Dialysis Patients With Chronic Renal Anemia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Roche
- 09 Oct 2015 New trial record